Literature DB >> 29470162

Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time.

Mark M Hammer1, Rachna Madan1, Hiroto Hatabu1.   

Abstract

OBJECTIVE: Pulmonary mucormycosis is an aggressive opportunistic fungal infection. We set out to evaluate the CT and MRI features of pulmonary mucormycosis.
MATERIALS AND METHODS: Through a search of the electronic medical record from 2007 to 2017, we identified 30 patients with definite or probable mucormycosis. Two radiologists reviewed the initial chest CT examinations for the presence of features including the "reverse halo" sign, large ground-glass halo, and peripheral lesion distribution. Additional CT and MRI studies were reviewed to evaluate evolution over time.
RESULTS: The majority (67%) of patients had lesions with the reverse halo sign at some point in the disease course. A ground-glass halo larger than the lesion was seen in 53% of patients. Notably, lesions had a peripheral predominance in 87% of cases. Through careful review of images, a perivascular ground-glass precursor lesion was identified in 20% of patients 1-2 weeks before a consolidation developed. In five (17%) patients, CT showed a multifocal pneumonia appearance. Finally, MRI of two patients showed T2-hypointense rims and central nonenhancement, a finding we refer to as the "black hole" sign.
CONCLUSION: Large nodules or consolidations with an associated reverse halo sign or large perilesional ground-glass halos are common in mucormycosis. Lesions tend to show a peripheral predominance, and a perivascular ground-glass focus preceded nodular lesions in some cases. In some patients with severe disease, imaging features evolved to show a multifocal pneumonia pattern, and this pattern was associated with a high mortality rate.

Entities:  

Keywords:  Zygomycetes; angioinvasive fungal infection; mucormycosis; reverse halo sign

Mesh:

Year:  2018        PMID: 29470162     DOI: 10.2214/AJR.17.18792

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Reverse halo sign in uncontrolled patient with type 2 diabetes.

Authors:  Pawan Kumar Singh; Puneet Saxena
Journal:  BMJ Case Rep       Date:  2019-06-18

Review 2.  Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.

Authors:  Jing Bao; Chunyu Liu; Yongxia Dong; Yu Xu; Zhanwei Wang; Kunkun Sun; Wen Xi; Keqiang Wang; Pihua Gong; Zhancheng Gao
Journal:  Can Respir J       Date:  2022-06-02       Impact factor: 2.130

Review 3.  CT appearance of gastrointestinal tract mucormycosis.

Authors:  Samarjit Singh Ghuman; Pendyala Sindhu; T B S Buxi; Swapnil Sheth; Anurag Yadav; Kishan Singh Rawat; Seema Sud
Journal:  Abdom Radiol (NY)       Date:  2020-11-10

Review 4.  Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.

Authors:  Ayushi Sharma; Anjana Goel
Journal:  Folia Microbiol (Praha)       Date:  2022-02-26       Impact factor: 2.629

5.  The Integral Role of Radiology in the Diagnosis and Management of COVID-19-Associated Mucormycosis Infections.

Authors:  Anuj Prabhakar; Nidhi Prabhakar; Mandeep Garg; Ajay Kumar
Journal:  Am J Trop Med Hyg       Date:  2022-02-09       Impact factor: 2.345

6.  Radiological spectrum of invasive mucormycosis in COVID-19.

Authors:  Nandini Passi; Anshu C Wadhwa; Swati Naik
Journal:  BJR Case Rep       Date:  2022-03-09

Review 7.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

Review 8.  Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic.

Authors:  A S Fathima; Vakada Lakshmi Mounika; V Udaya Kumar; Ashok Kumar Gupta; Pavan Garapati; V Ravichandiran; Sameer Dhingra; Krishna Murti
Journal:  Health Sci Rev (Oxf)       Date:  2021-12-03

9.  Mucor pulmonary embolism in a patient with myelodysplastic syndrome.

Authors:  T Kakuwa; A Ariga; J Takasaki; M Kato; T Igari; Y Shida; T Okafuji; S Nakamura; Y Miyazaki; H Katano; M Iikura; S Izumi; H Sugiyama
Journal:  Respir Med Case Rep       Date:  2020-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.